Terms: = Germ cell tumor AND SETBP1, Q9UEF3, Q6P6C3, A6H8W5, Q9Y6X0, 26040, SEB, KIAA0437, ENSG00000152217
8 results:
1. Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
Kim N; Lee J; Nam DH; Lee JI; Seol HJ; Kong DS; Choi JW; Chong K; Lee WJ; Chang JH; Kang SG; Moon JH; Cho J; Lim DH; Yoon HI
J Neurooncol; 2023 Nov; 165(2):261-268. PubMed ID: 37861921
[TBL] [Abstract] [Full Text] [Related]
2. setbp1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC.
An F; Zhang W; Guo Y; Shi F; Kong Y; Tang L; Han C; Wang Q
Aging (Albany NY); 2023 Aug; 15(15):7476-7495. PubMed ID: 37535001
[TBL] [Abstract] [Full Text] [Related]
3. Targeting glioblastoma multiforme using a novel fusion protein comprising interleukin-13 and staphylococcal enterotoxin B in vitro.
Gholipour Z; Fooladi AAI; Parivar K; Halabian R
Toxicol In Vitro; 2023 Oct; 92():105651. PubMed ID: 37482138
[TBL] [Abstract] [Full Text] [Related]
4. Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese Cohort.
Ban X; Mo S; Lu Z; Jia C; Shao H; Yan J; Chang X; Mao X; Wu Y; Zhang Y; Fan X; Yu S; Chen J
Neuroendocrinology; 2022; 112(5):510-522. PubMed ID: 34348341
[TBL] [Abstract] [Full Text] [Related]
5. Endogenous HLA-DQ8αβ programs superantigens (SEG/SEI) to silence toxicity and unleash a tumoricidal network with long-term melanoma survival.
Knopick P; Terman D; Riha N; Alvine T; Larson R; Badiou C; Lina G; Ballantyne J; Bradley D
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33109631
[TBL] [Abstract] [Full Text] [Related]
6. Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas.
Farzin M; Molls M; Astner S; Rondak IC; Oechsner M
Strahlenther Onkol; 2015 Dec; 191(12):945-52. PubMed ID: 26340939
[TBL] [Abstract] [Full Text] [Related]
7. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience.
Thomas CJ; Wood GC; Marks VJ
Dermatol Surg; 2007 Mar; 33(3):333-9. PubMed ID: 17338692
[TBL] [Abstract] [Full Text] [Related]
8. Bifunctional antibody retargeting in vivo-activated T lymphocytes: simplifying clinical application.
Chapoval AI; Nelson H; Thibault C; Penna C; Dean P
J Hematother; 1995 Dec; 4(6):571-7. PubMed ID: 8846018
[TBL] [Abstract] [Full Text] [Related]
